Description: This talk will provide specific and evidence-based guidance for managing patients with opioid use disorder in the ED. Topics covered will include specifics on supportive care and symptom management, buprenorphine, and proper discharge instructions.
At the end of this presentation, participants will be able to:
- Be familiar with the evidence supporting ED-initiated opioid agonist therapy and understand the necessary culture change required to accept this option.
- Identify patients who are appropriate for ED- initiated opioid agonist therapy and describe the approach to initiating buprenorphine in the ED.
- Know the indications, dosing, and possible adverse events for non-opioid treatments in opioid withdrawal.
- ED-initiated buprenorphine reduces opioid-related mortality; EDs are well positioned to optimize the small window of opportunity for intervention.
- Patients must be in moderate to severe withdrawal at the time of buprenorphine initiation as per the COWS scale.
- Discharge instructions must include naloxone kit, specific buprenorphine dosing advice, and clear follow up plan.